Accelerated hypofractionated breast radiotherapy: FAQs (Frequently Asked Questions) and facts

Breast

Volumn 23, Issue 4, 2014, Pages 299-309

  Montero, Angel ^a   Sanz, Xavier ^a   Hernanz, Raul ^a   Cabrera, Dolores ^a   Arenas, Meritxell ^a   Bayo, Eloisa ^a   Moreno, Ferran ^a   Algara, Manel ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Accelerated treatment; Altered fractionation; Breast cancer; Hypofractionation; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCELERATED HYPOFRACTIONATED BREAST RADIOTHERAPY; ADVANCED CANCER; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; MASTECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION TOXICITY; RELIABILITY; REVIEW; TREATMENT INDICATION; ADJUVANT THERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; PROCEDURES;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY; RADIOTHERAPY, ADJUVANT;

EID: 84902545116     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2014.01.011     Document Type: Review

References (72)

1. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013 Apr, 49(6):1374-1403.
2. Malvezzi M., Bertuccio P., Levi F., La Vecchia C., Negri E. European cancer mortality predictions for the year 2013. Ann Oncol 2013 Mar, 24(3):792-800.
3. Harnett A. Fewer fractions of adjuvant external beam radiotherapy for early breast cancer are safe and effective and can now be the standard of care. Why the UK's NICE accepts fewer fractions as the standard of care for adjuvant radiotherapy in early breast cancer. Breast 2010, 19(3):159-162.
4. Khan A., Haffty B.G. Hypofractionation in adjuvant breast radiotherapy. Breast 2010, 19(3):168-171.
5. Théberge V., Whelan T., Shaitelman S.F., Vicini F.A. Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. Semin Radiat Oncol 2011, 21(1):55-65.
6. Yarnold J., Haviland J. Hypofractionated adjuvant whole breast radiotherapy: progress and prospects. Acta Oncol 2010, 49(8):1288-1292.
7. Jones B., Dale R.G., Deehan C., Hopkins K.I., Morgan D.A. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 2001, 13(2):71-81.
8. Qi S.X., White J., Li A. Is α/β for breast cancer really low?. Radiother Oncol 2011, 100(2):282-288.
9. Yarnold J., Bentzen S.M., Coles C., Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011 Jan 1, 79(1):1-9.
10. Tutt A., Yarnold J. Radiobiology of breast cancer. Clin Oncol (R Coll Radiol) 2006, 18(3):166-178.
11. Yarnold J., Haviland J., Bentzen S.M., Sydenham M., Owen R., Bliss J. Estimation of an overall treatment time factor for local relapse after adjuvant radiotherapy for early breast cancer by the UK START Trialists' Group. Eur J Cancer 2013, 49(Suppl.2):S2405.
12. Kim J.J., Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev 2005, 5:516-525.
13. Baillet F., Housset M., Maylin C., Boisserie G., Bettahar R., Delanian S., et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int J Radiat Oncol Biol Phys 1990, 19(5):1131-1133.
14. Magee B., Swindell R., Harris M., Banerjee S.S. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomized trial. Radiother Oncol 1996, 39(3):223-227.
15. Clark R.M., Whelan T., Levine M., Roberts R., Willan A., McCulloch P., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. JNatl Cancer Inst 1996 Nov 20, 88(22):1659-1664.
16. Whelan T., MacKenzie R., Julian J., Levine M., Shelley W., Grimard L., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph nodenegative breast cancer. JNatl Cancer Inst 2002, 94:1143-1150.
17. Whelan T., Pignol J.P., Levine M.N., Julian J.A., MacKenzie R., Parpia S., et al. Long-term results of hypofractionated radiation therapy for breast cancer. NEngl J Med 2010, 362:513-520.
18. START Trialists' Group, Bentzen S.M., Agrawal R.K., Aird E.G., Barrett J.M., Barrett-Lee P.J., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9(4):331-341.
19. START Trialists' Group, Bentzen S.M., Agrawal R.K., Aird E.G., Barrett J.M., Barrett-Lee P.J., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371(9618):1098-1107.
20. Haviland J.S., Owen J.R., Dewar J.A., Agrawal R.K., Barrett J., Barrett-Lee P.J., et al. START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013 Oct, 14(11):1086-1094.
21. Tjessem K.H., Johansen S., Malinen E., Reinertsen K.V., Danielsen T., Fosså S.D., et al. Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys 2013 Oct 1, 87(2):337-343.
22. Darby S.C., Ewertz M., McGale P., Bennet A.M., Blom-Goldman U., Brønnum D., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. NEngl J Med 2013, 368:987-998.
23. Appelt A.L., Vogelius I.R., Bentzen S.M. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol R Coll Radiol 2013 Mar, 25(3):147-152.
24. Bentzen S.M., Dische S. Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol 2000, 39(3):337-347.
25. Friberg S., Rudén B.I. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast. Acta Oncol 2009, 48(6):822-831.
26. Gałecki J., Hicer-Grzenkowicz J., Grudzień-Kowalska M., Michalska T., Załucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer - a review. Acta Oncol 2006, 45(3):280-284.
27. Fehlauer F., Tribius S., Alberti W., Rades D. Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol 2005, 181(10):625-631.
28. Owen J.R., Ashton A., Bliss J.M., Homewood J., Harper C., Hanson J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006 Jun, 7(6):467-471.
29. Lee L.J., Harris J.R. Innovations in radiation therapy (RT) for breast cancer. Breast 2009, 18(Suppl.3):S103-S111.
30. Mukesh M.B., Barnett G.C., Wilkinson J.S., Moody A.M., Wilson C., Dorling L., et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. JClin Oncol 2013, 31(36):4488-4495.
31. Nissen H.D., Appelt A.L. Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol 2013 Jan, 106(1):28-32.
32. Formenti S.C., DeWyngaert J.K., Jozsef G., Goldberg J.D. Prone vs. supine positioning for breast cancer radiotherapy. JAm Med Assoc 2012, 308:861-863.
33. Mulliez T., Veldeman L., van Greveling A., Speleers B., Sadeghi S., Berwouts D., et al. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol 2013 Aug, 108(2):203-208.
34. Brenner D.J., Shuryak I., Jozsef G., DeWyngaert K.J., Formenti S.C. Risk and risk reduction of major coronary events associated with contemporary breast radiotherapy. JAMA Intern Med 2013, 10.1001/jamainternmed.2013.11790.
35. Haviland J.S., Yarnold J.R., Bentzen S.M. Hypofractionated radiotherapy for breast cancer. NEngl J Med 2010, 362(19):1843. [author reply 1843-4].
36. Herbert C., Nichol A., Olivotto I., Weir L., Woods R., Speers C., et al. The impact of hypofractionated whole breast radiotherapy on local relapse in patients with grade 3 early breast cancer: a population-based cohort study. Int J Radiat Oncol Biol Phys 2012 Apr 1, 82(5):2086-2092. 31.
37. Schoenfeld J.D., Harris J.R. Abbreviated course of radiotherapy (RT) for breast cancer. Breast 2011 Oct, 20(Suppl.3):S116-S127.
38. Bartelink H., Horiot J.C., Poortmans P.M., Struikmans H., Van den Bogaert W., Fourquet A., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. JClin Oncol 2007 Aug 1, 25(22):3259-3265.
39. Poortmans P. Optimal approach in early breast cancer: radiation therapy. Eur J Cancer 2013, 11:27-36.
40. Smith B.D., Bentzen S.M., Correa C.R., Hahn C.A., Hardenbergh P.H., Ibbott G.S., et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011 Sep 1, 81(1):59-68.
41. Corbin K.S., Dorn P.L., Jain S.K., Al-Hallaq H.A., Hasan Y., Chmura S.J. Hypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected series. Am J Clin Oncol 2013, 10.1097/COC.0b013e31827b45b7.
42. Hannan R., Thompson R.F., Chen Y., Bernstein K., Kabarriti R., Skinner W., et al. Hypofractionated whole-breast radiation therapy: does breast size matter?. Int J Radiat Oncol Biol Phys 2012, 84(4):894-901.
43. Goldsmith C., Haviland J., Tsang Y., Sydenham M., Yarnold J. FAST Trialists' Group. Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?. Radiother Oncol 2011 Aug, 100(2):236-240.
44. Williamson D., Dinniwell R., Fung S., Pintilie M., Done S.J., Fyles A.W. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ. Radiother Oncol 2010, 95(3):317-320.
45. Wai E.S., Lesperance M.L., Alexander C.S., Truong P.T., Culp M., Moccia P., et al. Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 2011, 117(1):54-62.
46. Ciervide R., Dhage S., Guth A., Shapiro R.L., Axelrod D.M., Roses D.F., et al. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. Int J Radiat Oncol Biol Phys 2012, 83(2):e159-e164.
47. Hathout L., Hijal T., Théberge V., Fortin B., Vulpe H., Hogue J.C., et al. Hypofractionated radiation therapy for breast ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2013 Oct 8, S0360-3016(13)03032-0. 10.1016/j.ijrobp.2013.08.026.
48. Ragaz J., Olivotto I.A., Spinelli J.J., Phillips N., Jackson S.M., Wilson K.S., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. JNatl Cancer Inst 2005, 97(2):116-126.
49. Yadav B.S., Sharma S.C., Singh R., Singh G., Kumar V. Post-mastectomy radiation and survival in patients with breast cancer. JCan Res Ther 2007, 3:218-224.
50. El-Sayed M.I., Abdel-Wanis M.E. Comparison of hypofractionated and conventional radiotherapy protocols in breast cancer patients: a retrospective study. JCancer Sci Ther 2012, 4:158-163. 10.4172/1948-5956.1000132.
51. Hijal T., Al Hamad A.A., Niazi T., Sultanem K., Bahoric B., Vuong T., et al. Hypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patients. Curr Oncol 2010 Oct, 17(5):22-27.
52. Moorthy S., Elhateer H., Das Majumdar S.K., Shubber, Zainab, Murthy N.P. Hypofractionated IMRT breast treatment with simultaneous versus sequential boost techniques. JNucl Med Radiat Ther 2012, 3:130. 10.4172/2155-9619.1000130.
53. Chadha M., Woode R., Sillanpaa J., Lucido D., Boolbol S.K., Kirstein L., et al. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost. Int J Radiat Oncol Biol Phys 2013, 86:40-44. 10.1016/j.ijrobp.2012.11.010.
54. Cante D., Rosa La Porta M., Casanova-Borca V., Sciacero P., Girelli G., Pasquino M., et al. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. Breast J 2011, 17(6):586-593.
55. Freedman G.M., White J.R., Arthur D.W., Allen Li X., Vicini F.A. Accelerated fractionation with a concurrent boost for early stage breast cancer. Radiother Oncol 2013 Jan, 106(1):15-20.
56. Formenti S.C., Gidea-Addeo D., Goldberg J.D., Roses D.F., Guth A., Rosenstein B.S., et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. JClin Oncol 2007, 25(16):2236-2242.
57. Scorsetti M., Alongi F., Fogliata A., Pentimalli S., Navarria P., Lobefalo F., et al. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. Radiat Oncol 2012, 7:145. 10.1186/1748-717X-7-145.
58. Sedlmayer F., Sautter-Bihl M.L., Budach W., Dunst J., Feyer P., Fietkau R., et al. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol 2013, 189:193-196.
59. Coles C., Yarnold J. The IMPORT trials are launched (September 2006). Clin Oncol (R Coll Radiol) 2006, 18:587-590.
60. Higher-dose radiation therapy or standard radiation therapy in treating patients with early-stage breast cancer that was removed by surgery. Available at: http://clinicaltrials.gov/ct2/show/NCT01349322.
61. Van Parijs H., Miedema G., Vinh-Hung V., Verbanck S., Adriaenssens N., Kerkhove D., et al. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trail. Radiat Oncol 2012, 7:80. 10.1186/1748-717X-7-80.
62. Mannino M., Yarnold J.R. Shorter fractionation schedules in breast cancer radiotherapy: clinical and economic implications. Eur J Cancer 2009, 45(5):730-731.
63. Suh W.W., Pierce L.J., Vicini F.A., Hayman J.A. Acost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005 Jul 1, 62(3):790-796.
64. Lievens Y. Hypofractionated breast radiotherapy: financial and economic consequences. Breast 2010, 19(3):192-197.
65. Dwyer P., Hickey B., Burmeister E., Burmeister B. Hypofractionated whole-breast radiotherapy: impact on departmental waiting times and cost. JMed Imaging Radiat Oncol 2010, 54(3):229-234.
66. Lanni T., Keisch M., Shah C., Wobb J., Kestin L., Vicini F. Acost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery. Breast J 2013 Mar-Apr, 19(2):162-167.
67. Amin N., Konski A.A. Is hypofractionation the solution? The financial implications of breast cancer treatments. Oncology (Williston Park) 2013 Apr, 27(4):342-344.
68. Kirova Y.M., Campana F., Savignoni A., Laki F., Muresan M., Dendale R., et al. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75(1):76-81.
69. Ortholan C., Hannoun-Lévi J.-M., Ferrero J.-M., Largillier R., Courdi A. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Biol Phys 2005, 61(1):154-162.
70. Trialists group F.A.S.T., Agrawal R.K., Alhasso A., Barrett-Lee P.J., Bliss J.M., Bliss P., et al. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 2011 Jul, 100(1):93-100.
71. Yarnold J. Breast radiotherapy: fractionation and other fashions. Cancer Res 2012, 72(Suppl.24). [Abstract nr PL-3].
72. Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.